Interim CFO Paul Murphy listed as insider at Trinity Biotech (TRIB)

Rhea-AI Filing Summary

TRINITY BIOTECH PLC filed a Form 3 to report that Paul Murphy, the company’s Interim CFO, is now an insider required to report holdings and future trades in the company’s securities. The filing lists no initial share or option positions and shows no buy, sell, or exercise activity.

Key Terms

Form 3, Interim CFO, ten percent owner

3 terms

Form 3 regulatory

"TRINITY BIOTECH PLC filed a Form 3 to report"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Interim CFO financial

"the company’s Interim CFO, is now an insider"

An interim CFO is a temporary chief financial officer hired to run a company’s finance operations during a leadership transition, a search for a permanent hire, or while specific financial issues are resolved. Investors pay attention because this person manages budgeting, financial reporting and communications with shareholders—like a substitute driver keeping a car on course—so their competence affects short‑term financial stability, the accuracy of public reports, and market confidence.

ten percent owner financial

"is_ten_percent_owner": 0"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Murphy Paul

(Last) (First) (Middle)

TRINITY BIOTECH PLC

IDA BUSINESS PARK, WICKLOW

(Street)

BRAY A98 H5C8

(City) (State) (Zip)

IRELAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TRINITY BIOTECH PLC [ TRIB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Paul Murphy	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the TRINITY BIOTECH PLC (TRIB) Form 3 for Paul Murphy show?

The Form 3 shows Interim CFO Paul Murphy as a reporting insider of TRINITY BIOTECH PLC. It reports no initial common stock or derivative holdings and records no buy, sell, exercise, or other transactions at the time of this filing.

Did Interim CFO Paul Murphy buy or sell TRINITY BIOTECH (TRIB) shares in this Form 3?

No transactions are reported for Interim CFO Paul Murphy in this Form 3. The transaction summary shows zero buys, zero sells, zero exercises, and zero other dispositions, indicating this filing only establishes his insider reporting status.

Does the TRIB Form 3 for Paul Murphy report any option or derivative positions?

The Form 3 lists no derivative positions for Paul Murphy. The derivative summary is empty and the exercise-related fields in the transaction summary are all zero, so no options, warrants, or other derivatives are reported as of this filing.

What is Paul Murphy’s role at TRINITY BIOTECH PLC in this Form 3?

The Form 3 identifies Paul Murphy as an officer of TRINITY BIOTECH PLC with the title Interim CFO. This status subjects him to ongoing insider reporting obligations for his holdings and future transactions in the company’s securities.

Does the TRIB Form 3 indicate Paul Murphy is a 10% owner of the company?

The Form 3 indicates that Paul Murphy is not a ten percent owner of TRINITY BIOTECH PLC. The field for ten percent owner status is set to zero, confirming he is an officer insider but not a large beneficial owner.